Michael Rechtman
Papers
1
Total Citations
12
H-Index
1
About
Dr. Michael Rechtman is a leading urological outcomes researcher whose work focuses on the comparative effectiveness of surgical treatments for prostate cancer, particularly the real-world impact of robot-assisted versus open radical prostatectomy. His landmark 2022 study, which has garnered 12 citations, employed a rigorous propensity score-matched, population-based design in Victoria to compare urinary and sexual patient-reported outcomes between these two surgical approaches. This work is notable for challenging prevailing assumptions about the superiority of robotic surgery, providing critical evidence that helps guide shared decision-making between clinicians and patients. Dr. Rechtman’s research is distinguished by its methodological rigor and its emphasis on patient-centered outcomes, ensuring that surgical innovations are evaluated not just by technical metrics but by the quality of life they afford men undergoing prostate cancer treatment. His contributions are shaping how the urological community understands the trade-offs inherent in modern prostate cancer surgery, making him a vital voice in evidence-based surgical practice.
Research Focus
Key Achievements
Top Papers
- 1